Elaine Hardy
Family · Hackettstown, NJNPI 1063503878
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Salix Pharmaceuticals, A Division Of Bausch Health US, LLC accounts for 71.3% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $3,780 and has fallen 71.7% since, to $1,068 in 2025. Among family clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $45.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$8K
- AbbVie$932
- Novo Nordisk$582
- Otsuka America Pharmaceutical, Inc.$415
- Axsome Therapeutics, Inc.$348
- Acella Pharmaceuticals, LLC$141
- plus $733 from 15 others
What the payments were for
- Consulting fees$7006%
- Speaking & faculty fees$5,21547%
- Travel & lodging$4334%
- Food & beverage$4,65342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,000 in reported general payments places this provider in the 95th percentile of 2,692 family providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 41 | $48,106 |
| RexultiBrexpiprazole | 21 | $28,691 |
| GemtesaVibegron | 13 | $7,780 |
| Np ThyroidThyroid,pork | 22 | $1,919 |
| Mesalamine | 20 | $1,850 |
| Armour ThyroidThyroid,pork | 15 | $1,244 |
| Liothyronine Sodium | 24 | $1,017 |
| Mirtazapine | 20 | $934 |
| Estradiol | 13 | $835 |
| ProgesteroneProgesterone, Micronized | 32 | $806 |
| SynthroidLevothyroxine Sodium | 13 | $613 |
| Levothyroxine Sodium | 76 | $578 |
| Clonazepam | 31 | $415 |
| Alprazolam | 46 | $294 |
| Duloxetine Hcl | 21 | $285 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $15 | $48,10641 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $415 | $28,69121 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $141 | $1,91922 claims |
| AbbVieArmour Thyroid, Synthroid | $932 | $1,85728 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,692 family providers in New Jersey.
Other family in Hackettstown
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
- Toni Michelle SeibertColumbus$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.